×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61

Bryan, Garnier & Co Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Bryan, Garnier & Co. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Bryan, Garnier & Co.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
CMPGY
Compass Group
6/9/2022Upgraded byBryan, Garnier & CoNeutral -> BuyMedium
ZLNDY
Zalando
6/1/2022Downgraded byBryan, Garnier & CoAnalyst Clement GenelotNeutral -> Sell€87.00 -> €38.00High
GMAB
Genmab A/S
5/13/2022Upgraded byBryan, Garnier & CoAnalyst Victor FlochSell -> NeutralMedium
IPSEY
Ipsen
4/27/2022Downgraded byBryan, Garnier & CoBuy -> NeutralHigh
BLDR
Builders FirstSource
4/6/2022Downgraded byBryan, Garnier & CoBuy -> Neutral $71.00High
MTLS
Materialise
3/25/2022Downgraded byBryan, Garnier & CoAnalyst Gregory RamirezBuy -> Neutral $20.00Low
DASTY
Dassault Systèmes
3/25/2022Downgraded byBryan, Garnier & CoAnalyst Gregory RamirezBuy -> Neutral €49.00High
TIIAY
Telecom Italia
3/14/2022Upgraded byBryan, Garnier & CoAnalyst Thomas CoudryNeutral -> BuyMedium
ZLNDY
Zalando
3/4/2022Downgraded byBryan, Garnier & CoNeutralHigh
GLPG
Galapagos
1/28/2022Upgraded byBryan, Garnier & CoSell -> BuyHigh
NVS
Novartis
12/3/2021Reiterated byBryan, Garnier & CoAnalyst Jeanjacques LeBuy -> Neutral$115.00 -> $85.00Low
AZN
AstraZeneca
11/22/2021Downgraded byBryan, Garnier & CoBuyLow
ESLOY
EssilorLuxottica Société anonyme
10/29/2021Upgraded byBryan, Garnier & CoAnalyst Cedric RossiNeutral -> BuyHigh
MTTRY
Ceconomy
10/12/2021Downgraded byBryan, Garnier & CoAnalyst Clement GenelotBuy -> NeutralLow
BNTX
BioNTech
10/5/2021Target Set byBryan, Garnier & CoAnalyst Olga Smolentseva $359.00Low
BNTX
BioNTech
9/24/2021Target Set byBryan, Garnier & CoAnalyst Olga Smolentseva $451.00High
VALN
Valneva
9/13/2021Downgraded byBryan, Garnier & CoAnalyst Jean-Jacques Le FurBuy -> NeutralHigh
BNTX
BioNTech
8/11/2021Upgraded byBryan, Garnier & CoAnalyst Olga SmolentsevaNeutral -> BuyHigh
BOUYF
Bouygues
7/27/2021Upgraded byBryan, Garnier & CoAnalyst Thomas CoudryNeutral -> Buy $37.20Low
AEXAY
Atos
7/13/2021Downgraded byBryan, Garnier & CoAnalyst Gregory RamirezBuy -> SellMedium
MOR
MorphoSys
6/3/2021Downgraded byBryan, Garnier & CoBuy -> NeutralMedium
BNTX
BioNTech
5/17/2021Reiterated byBryan, Garnier & CoBuy -> Neutral$135.00 -> $206.00N/A
BAYRY
Bayer Aktiengesellschaft
5/13/2021Upgraded byBryan, Garnier & CoSell -> NeutralLow
BNTX
BioNTech
5/11/2021Downgraded byBryan, Garnier & CoBuy -> Neutral$135.00 -> $206.00Low
BUD
Anheuser-Busch InBev SA/NV
5/6/2021Upgraded byBryan, Garnier & CoSell -> BuyMedium
DBVT
DBV Technologies
5/3/2021Upgraded byBryan, Garnier & CoSell -> BuyLow
AEXAY
Atos
4/6/2021Downgraded byBryan, Garnier & CoBuyLow
MTLS
Materialise
3/10/2021Upgraded byBryan, Garnier & CoNeutral -> Buy $43.00High
ECIFY
Electricité de France
2/24/2021Downgraded byBryan, Garnier & CoNeutral -> SellLow
GNFT
Genfit
2/12/2021Upgraded byBryan, Garnier & CoNeutral -> BuyLow
DASTY
Dassault Systèmes
2/5/2021Upgraded byBryan, Garnier & CoSell -> BuyLow
VCISY
Vinci
1/14/2021Upgraded byBryan, Garnier & CoSell -> NeutralMedium
STM
STMicroelectronics
1/8/2021Upgraded byBryan, Garnier & CoNeutral -> BuyHigh
GLPG
Galapagos
12/17/2020Downgraded byBryan, Garnier & CoBuy -> SellHigh
SCRYY
Scor
12/17/2020Downgraded byBryan, Garnier & CoBuyLow
STM
STMicroelectronics
12/10/2020Downgraded byBryan, Garnier & CoBuy -> NeutralLow
IPSEY
Ipsen
12/2/2020Downgraded byBryan, Garnier & CoBuy -> NeutralLow
BAYRY
Bayer Aktiengesellschaft
10/1/2020Downgraded byBryan, Garnier & CoNeutral -> SellHigh
GMAB
Genmab A/S
9/23/2020Downgraded byBryan, Garnier & CoNeutral -> SellHigh
IHG
InterContinental Hotels Group
9/21/2020Downgraded byBryan, Garnier & CoNeutral -> SellLow
IPHA
Innate Pharma
9/9/2020Downgraded byBryan, Garnier & CoBuy -> NeutralLow
DBVT
DBV Technologies
8/4/2020Downgraded byBryan, Garnier & CoNeutral -> SellHigh
BUD
Anheuser-Busch InBev SA/NV
7/15/2020Downgraded byBryan, Garnier & CoBuy -> SellLow
TAP
Molson Coors Beverage
7/15/2020Upgraded byBryan, Garnier & CoSell -> Buy $49.00Low
DEO
Diageo
7/8/2020Upgraded byBryan, Garnier & CoNeutral -> BuyLow
BNTX
BioNTech
7/2/2020Target Raised byBryan, Garnier & Co$50.00 -> $62.00High
HEXO
HEXO
7/1/2020Downgraded byBryan, Garnier & CoBuy -> SellMedium
STM
STMicroelectronics
6/29/2020Upgraded byBryan, Garnier & CoNeutral -> BuyLow
GMAB
Genmab A/S
6/3/2020Downgraded byBryan, Garnier & CoBuy -> NeutralLow
AZN
AstraZeneca
6/2/2020Target Raised byBryan, Garnier & CoBuyGBX 8,780 -> GBX 9,100N/A
CGC
Canopy Growth
6/1/2020Downgraded byBryan, Garnier & CoNeutral -> SellHigh
GNFT
Genfit
5/13/2020Downgraded byBryan, Garnier & CoBuy -> NeutralMedium
AZN
AstraZeneca
5/11/2020Target Raised byBryan, Garnier & CoBuyGBX 8,550 -> GBX 8,780N/A
ORAN
Orange
3/27/2020Upgraded byBryan, Garnier & CoNeutral -> BuyLow
DBVT
DBV Technologies
3/18/2020Downgraded byBryan, Garnier & CoBuy -> NeutralHigh
SGE
The Sage Group
3/2/2020Target Lowered byBryan, Garnier & CoNeutralGBX 690 -> GBX 680N/A
BUD
Anheuser-Busch InBev SA/NV
2/28/2020Downgraded byBryan, Garnier & CoBuy -> NeutralHigh
ACB
Aurora Cannabis
2/27/2020Downgraded byBryan, Garnier & CoNeutral -> SellLow
GSK
GSK
2/6/2020Target Lowered byBryan, Garnier & CoNeutralGBX 1,800 -> GBX 1,773N/A
SAP
SAP
1/28/2020Target Set byBryan, Garnier & CoBuy €153.00N/A
BRBY
Burberry Group
1/10/2020Target Raised byBryan, Garnier & CoNeutralGBX 1,780 -> GBX 1,860N/A
AZN
AstraZeneca
12/19/2019Reiterated byBryan, Garnier & CoBuyN/A
GSK
GSK
12/19/2019Target Raised byBryan, Garnier & CoNeutralGBX 1,660 -> GBX 1,747N/A
ORAN
Orange
12/5/2019Downgraded byBryan, Garnier & CoBuy -> NeutralLow
AZN
AstraZeneca
11/25/2019Upgraded byBryan, Garnier & CoBuyGBX 7,700 -> GBX 7,950N/A
TAP
Molson Coors Beverage
8/1/2019Reiterated byBryan, Garnier & CoNeutral -> Sell $51.00High
CGC
Canopy Growth
7/5/2019Downgraded byBryan, Garnier & CoBuy -> NeutralLow
WEED
Canopy Growth
7/4/2019Downgraded byBryan, Garnier & CoBuy -> NeutralC$85.00 -> C$60.00N/A
AZN
AstraZeneca
7/3/2019Reiterated byBryan, Garnier & CoNeutralN/A
BURBY
Burberry Group
5/20/2019Upgraded byBryan, Garnier & CoSell -> NeutralLow
BRBY
Burberry Group
5/20/2019Upgraded byBryan, Garnier & CoNeutralN/A
ADDYY
adidas
5/6/2019Downgraded byBryan, Garnier & CoBuy -> NeutralHigh
GSK
GSK
5/2/2019Target Lowered byBryan, Garnier & CoNeutralGBX 1,710 -> GBX 1,660N/A
PDRDY
Pernod Ricard
3/29/2019Downgraded byBryan, Garnier & CoBuy -> NeutralLow
AZN
AstraZeneca
3/29/2019Reiterated byBryan, Garnier & CoNeutralN/A
BAYRY
Bayer Aktiengesellschaft
3/28/2019Downgraded byBryan, Garnier & CoNeutral -> SellLow
AZN
AstraZeneca
2/22/2019Downgraded byBryan, Garnier & CoNeutralN/A
IHG
InterContinental Hotels Group
2/19/2019Reiterated byBryan, Garnier & CoSellN/A
SGE
The Sage Group
1/17/2019Target Lowered byBryan, Garnier & CoBuyGBX 850 -> GBX 630N/A
AZN
AstraZeneca
11/8/2018Downgraded byBryan, Garnier & CoNeutralN/A
LVMUY
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
4/24/2018Upgraded byBryan, Garnier & CoNeutral -> BuyMedium
SOW
Software Aktiengesellschaft
4/17/2018Target Set byBryan, Garnier & CoBuy €49.00N/A
MOR
MorphoSys
4/9/2018Target Set byBryan, Garnier & CoBuy €91.00N/A
SAP
SAP
4/6/2018Target Set byBryan, Garnier & CoBuy €112.00N/A
MOR
MorphoSys
3/14/2018Target Set byBryan, Garnier & CoBuy €91.20N/A
IGY
innogy SE (IGY.F)
3/12/2018Target Set byBryan, Garnier & CoNeutral €31.00N/A
IHG
InterContinental Hotels Group
2/20/2018Reiterated byBryan, Garnier & CoSell GBX 4,100N/A
ONC
Oncimmune
2/13/2018Target Raised byBryan, Garnier & CoBuyGBX 154 -> GBX 168N/A
DGE
Diageo
1/25/2018Reiterated byBryan, Garnier & CoNeutral GBX 2,320N/A
SGE
The Sage Group
1/25/2018Target Lowered byBryan, Garnier & CoBuyGBX 860 -> GBX 850N/A
AZN
AstraZeneca
12/15/2017Reiterated byBryan, Garnier & CoBuyN/A
SGE
The Sage Group
11/23/2017Target Raised byBryan, Garnier & CoBuyGBX 830 -> GBX 860N/A
BRBY
Burberry Group
11/10/2017Reiterated byBryan, Garnier & CoSellN/A
ULVR
Unilever
10/20/2017Reiterated byBryan, Garnier & CoNeutral GBX 4,350N/A
SGPYY
The Sage Group
9/24/2017Upgraded byBryan, Garnier & CoNeutral -> BuyN/A
SGPYY
The Sage Group
9/22/2017Upgraded byBryan, Garnier & CoNeutral -> BuyLow
SGE
The Sage Group
9/22/2017Upgraded byBryan, Garnier & CoBuyGBX 720 -> GBX 830N/A
GSK
GSK
9/19/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,710N/A
TSCO
Tesco
9/12/2017Reiterated byBryan, Garnier & CoSell GBX 170N/A
AZN
AstraZeneca
9/11/2017Upgraded byBryan, Garnier & CoBuyGBX 4,700 -> GBX 5,380N/A
BRBY
Burberry Group
9/11/2017Reiterated byBryan, Garnier & CoSellN/A
888
888
9/5/2017Reiterated byBryan, Garnier & CoBuy GBX 330N/A
CPG
Compass Group
8/29/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,550N/A
ULVR
Unilever
8/25/2017Reiterated byBryan, Garnier & CoNeutral GBX 4,300N/A
IHG
InterContinental Hotels Group
8/24/2017Reiterated byBryan, Garnier & CoSell GBX 3,520N/A
DGE
Diageo
8/23/2017Target Raised byBryan, Garnier & CoNeutralGBX 2,210 -> GBX 2,320N/A
GSK
GSK
7/26/2017Target Raised byBryan, Garnier & CoBuyGBX 1,750 -> GBX 1,790N/A
GSK
GSK
7/20/2017Reiterated byBryan, Garnier & CoBuy GBX 1,750N/A
TSCO
Tesco
6/20/2017Reiterated byBryan, Garnier & CoSell GBX 170N/A
TSCO
Tesco
6/14/2017Reiterated byBryan, Garnier & CoSell GBX 170N/A
GSK
GSK
5/31/2017Reiterated byBryan, Garnier & CoBuy GBX 1,750N/A
BRBY
Burberry Group
4/20/2017Reiterated byBryan, Garnier & CoSellN/A
BRBY
Burberry Group
4/13/2017Reiterated byBryan, Garnier & CoSell GBX 1,350N/A
TSCO
Tesco
4/13/2017Reiterated byBryan, Garnier & CoSell GBX 170N/A
TSCO
Tesco
3/23/2017Reiterated byBryan, Garnier & CoSell GBX 170N/A
DGE
Diageo
3/17/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,210N/A
SGE
The Sage Group
3/6/2017Target Raised byBryan, Garnier & CoNeutralGBX 640 -> GBX 660N/A
AZN
AstraZeneca
2/28/2017Reiterated byBryan, Garnier & CoBuy GBX 5,400N/A
IHG
InterContinental Hotels Group
2/21/2017Reiterated byBryan, Garnier & CoSell GBX 2,950N/A
CPG
Compass Group
2/3/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,475N/A
SGE
The Sage Group
2/1/2017Reiterated byBryan, Garnier & CoNeutral GBX 640N/A
TSCO
Tesco
1/30/2017Reiterated byBryan, Garnier & CoSell GBX 170N/A
ULVR
Unilever
1/27/2017Reiterated byBryan, Garnier & CoNeutral GBX 3,570N/A
DGE
Diageo
1/26/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,150N/A
SGE
The Sage Group
1/26/2017Reiterated byBryan, Garnier & CoNeutral GBX 650N/A
BRBY
Burberry Group
1/18/2017Reiterated byBryan, Garnier & CoSell GBX 1,350N/A
DGE
Diageo
1/16/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,150N/A
MRK
Merck & Co., Inc.
1/13/2017Initiated byBryan, Garnier & CoBuyN/A
BRBY
Burberry Group
1/10/2017Reiterated byBryan, Garnier & CoSell GBX 1,350N/A
CPG
Compass Group
1/9/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,430N/A
AZN
AstraZeneca
1/9/2017Reiterated byBryan, Garnier & CoBuy GBX 5,250N/A
GSK
GSK
1/9/2017Reiterated byBryan, Garnier & CoBuy GBX 1,850N/A
PNN
Pennon Group
1/6/2017Reiterated byBryan, Garnier & CoSell GBX 830N/A
BRBY
Burberry Group
1/4/2017Downgraded byBryan, Garnier & CoSell GBX 1,350N/A
DGE
Diageo
1/4/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,150N/A
ULVR
Unilever
1/4/2017Reiterated byBryan, Garnier & CoNeutral GBX 3,990N/A
TSCO
Tesco
1/4/2017Reiterated byBryan, Garnier & CoSell GBX 170N/A
AZN
AstraZeneca
12/12/2016Reiterated byBryan, Garnier & CoBuy GBX 5,100N/A
SGE
The Sage Group
11/30/2016Reiterated byBryan, Garnier & CoSell GBX 690N/A
CMPGY
Compass Group
11/25/2016Reiterated byBryan, Garnier & CoNeutralN/A
DGE
Diageo
11/23/2016Reiterated byBryan, Garnier & CoNeutralN/A
AZN
AstraZeneca
11/22/2016Reiterated byBryan, Garnier & CoBuy GBX 5,100N/A
CPG
Compass Group
11/22/2016Reiterated byBryan, Garnier & CoNeutral GBX 1,450N/A
AZN
AstraZeneca
10/26/2016Reiterated byBryan, Garnier & CoBuy GBX 5,220N/A
BRBY
Burberry Group
10/25/2016Target Raised byBryan, Garnier & CoNeutralGBX 1,260 -> GBX 1,350N/A
BRBY
Burberry Group
10/19/2016Target Raised byBryan, Garnier & CoNeutralGBX 1,200 -> GBX 1,250N/A
AZN
AstraZeneca
10/17/2016Reiterated byBryan, Garnier & CoBuy GBX 5,220N/A
GSK
GSK
10/17/2016Reiterated byBryan, Garnier & CoBuyN/A
SGE
The Sage Group
10/12/2016Target Raised byBryan, Garnier & CoSellGBX 600 -> GBX 690N/A
TSCO
Tesco
10/5/2016Reiterated byBryan, Garnier & CoSell GBX 166N/A
AZN
AstraZeneca
10/4/2016Target Lowered byBryan, Garnier & CoBuyGBX 5,400 -> GBX 5,220N/A
SGE
The Sage Group
9/30/2016Reiterated byBryan, Garnier & CoSell GBX 600N/A
IHG
InterContinental Hotels Group
9/27/2016Downgraded byBryan, Garnier & CoSellGBX 2,650 -> GBX 2,950N/A
AZN
AstraZeneca
7/28/2016Reiterated byBryan, Garnier & CoBuyN/A
GSK
GSK
7/28/2016Reiterated byBryan, Garnier & CoBuyN/A
TAP
Molson Coors Beverage
7/8/2016Upgraded byBryan, Garnier & CoBuyN/A
SGE
The Sage Group
5/5/2016Reiterated byBryan, Garnier & CoSell GBX 550N/A
TSCO
Tesco
4/4/2016Reiterated byBryan, Garnier & CoNeutral GBX 166N/A
CPG
Compass Group
4/4/2016Reiterated byBryan, Garnier & CoNeutral GBX 1,200N/A
AZN
AstraZeneca
3/10/2016Reiterated byBryan, Garnier & CoBuy GBX 5,520N/A
PNN
Pennon Group
2/11/2016Downgraded byBryan, Garnier & CoSell GBX 825N/A
PNN
Pennon Group
2/4/2016Reiterated byBryan, Garnier & CoNeutral GBX 800N/A
SGE
The Sage Group
1/28/2016Reiterated byBryan, Garnier & CoNeutral GBX 570N/A
GSK
GSK
1/27/2016Upgraded byBryan, Garnier & CoNeutral -> BuyN/A
GSK
GSK
1/27/2016Upgraded byBryan, Garnier & CoBuy GBX 1,635N/A
TSCO
Tesco
1/14/2016Initiated byBryan, Garnier & CoNeutral GBX 166N/A
PNN
Pennon Group
1/8/2016Reiterated byBryan, Garnier & CoNeutral GBX 800N/A
IHG
InterContinental Hotels Group
1/7/2016Reiterated byBryan, Garnier & CoNeutral GBX 2,650N/A
CPG
Compass Group
1/5/2016Target Raised byBryan, Garnier & CoNeutralGBX 1,150 -> GBX 1,200N/A
SGE
The Sage Group
12/18/2015Reiterated byBryan, Garnier & CoNeutral GBX 540N/A
GLPG
Galapagos
12/17/2015Target Raised byBryan, Garnier & CoBuy$52.00 -> $64.00N/A
DGE
Diageo
12/3/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,870N/A
TSCO
Tesco
12/1/2015Reiterated byBryan, Garnier & CoNeutralN/A
PNN
Pennon Group
11/27/2015Reiterated byBryan, Garnier & CoNeutral GBX 800N/A
SGE
The Sage Group
11/27/2015Reiterated byBryan, Garnier & CoNeutral GBX 540N/A
TSCDY
Tesco
11/25/2015Reiterated byBryan, Garnier & CoNeutralN/A
TSCO
Tesco
11/25/2015Initiated byBryan, Garnier & CoNeutralN/A
CPG
Compass Group
11/24/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,150N/A
TAP
Molson Coors Beverage
11/17/2015Initiated byBryan, Garnier & CoBuy $101.00N/A
SGE
The Sage Group
11/13/2015Reiterated byBryan, Garnier & CoNeutral GBX 540N/A
AZN
AstraZeneca
11/12/2015Target Raised byBryan, Garnier & CoBuyGBX 5,100 -> GBX 5,150N/A
SNY
Sanofi
11/9/2015Reiterated byBryan, Garnier & CoBuy -> NeutralN/A
PNN
Pennon Group
10/26/2015Reiterated byBryan, Garnier & CoNeutral GBX 800N/A
AZN
AstraZeneca
10/23/2015Reiterated byBryan, Garnier & CoBuy GBX 5,100N/A
UBSFY
Ubisoft Entertainment
10/15/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/A
AZN
AstraZeneca
10/12/2015Reiterated byBryan, Garnier & CoBuy GBX 5,400N/A
SGE
The Sage Group
10/6/2015Reiterated byBryan, Garnier & CoNeutral GBX 520N/A
IHG
InterContinental Hotels Group
10/5/2015Reiterated byBryan, Garnier & CoNeutralN/A
DGE
Diageo
10/1/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,870N/A
DGE
Diageo
9/23/2015Target Lowered byBryan, Garnier & CoNeutralGBX 1,920 -> GBX 1,870N/A
AZN
AstraZeneca
9/18/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/A
AZN
AstraZeneca
9/10/2015Reiterated byBryan, Garnier & CoNeutral GBX 4,830N/A
GSK
GSK
9/9/2015Target Lowered byBryan, Garnier & CoNeutralGBX 1,480 -> GBX 1,470N/A
PNN
Pennon Group
8/25/2015Reiterated byBryan, Garnier & CoNeutral GBX 835N/A
GSK
GSK
8/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,480N/A
AZN
AstraZeneca
8/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 4,830N/A
DGE
Diageo
7/29/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,920N/A
SGE
The Sage Group
7/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 520N/A
VCISY
Vinci
7/17/2015Initiated byBryan, Garnier & CoBuyN/A
DANOY
Danone
7/8/2015Initiated byBryan, Garnier & CoBuyN/A
DGE
Diageo
7/2/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,920N/A
DASTY
Dassault Systèmes
6/30/2015Downgraded byBryan, Garnier & CoNeutral -> SellN/A
NVS
Novartis
6/22/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/A
DLGNF
Dialog Semiconductor
6/11/2015Initiated byBryan, Garnier & CoBuyN/A
GSK
GSK
6/2/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,580N/A
IHG
InterContinental Hotels Group
5/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 2,650N/A
UBSFY
Ubisoft Entertainment
5/13/2015Downgraded byBryan, Garnier & CoBuy -> NeutralN/A
DGE
Diageo
5/6/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,950N/A
HEINY
Heineken
5/5/2015Initiated byBryan, Garnier & CoBuyN/A
BUD
Anheuser-Busch InBev SA/NV
5/5/2015Initiated byBryan, Garnier & CoNeutralN/A
AEG
Aegon
4/15/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/A
RANJY
Randstad
4/14/2015Upgraded byBryan, Garnier & CoSell -> BuyN/A
AZN
AstraZeneca
4/10/2015Reiterated byBryan, Garnier & CoNeutral GBX 4,740N/A
DGE
Diageo
4/1/2015Target Raised byBryan, Garnier & CoNeutralGBX 1,880 -> GBX 2,000N/A
CPG
Compass Group
3/30/2015Target Raised byBryan, Garnier & CoNeutralGBX 1,070 -> GBX 1,220N/A
PPRUY
Kering
2/18/2015Downgraded byBryan, Garnier & CoNeutralN/A
LVMUY
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
2/4/2015Upgraded byBryan, Garnier & CoBuyN/A
SGE
The Sage Group
1/29/2015Reiterated byBryan, Garnier & CoNeutral GBX 450N/A
RHHBY
Roche
1/28/2015Upgraded byBryan, Garnier & CoBuyN/A
SGE
The Sage Group
1/13/2015Reiterated byBryan, Garnier & CoNeutral GBX 420N/A
FMS
Fresenius Medical Care AG & Co. KGaA
12/18/2014Downgraded byBryan, Garnier & CoNeutralN/A
DEO
Diageo
12/4/2014Initiated byBryan, Garnier & CoNeutralN/A
SGE
The Sage Group
12/4/2014Reiterated byBryan, Garnier & CoNeutral GBX 425N/A
BOSSY
Hugo Boss
11/4/2014Initiated byBryan, Garnier & CoBuyN/A
VEOEY
Veolia Environnement
9/30/2014Initiated byBryan, Garnier & CoBuyN/A
SGE
The Sage Group
9/30/2014Reiterated byBryan, Garnier & CoNeutral GBX 405N/A
CRH
CRH
9/12/2014Upgraded byBryan, Garnier & CoSell -> BuyN/A
PDRDY
Pernod Ricard
8/29/2014Upgraded byBryan, Garnier & CoNeutral -> Buy $23.29N/A
SGE
The Sage Group
7/24/2014Reiterated byBryan, Garnier & CoNeutral GBX 395N/A
ENGIY
Engie
7/17/2014Initiated byBryan, Garnier & CoBuyN/A
PDRDY
Pernod Ricard
5/28/2014Initiated byBryan, Garnier & CoNeutralN/A
SGE
The Sage Group
4/17/2014Reiterated byBryan, Garnier & CoNeutral GBX 410N/A
AZN
AstraZeneca
12/20/2013Downgraded byBryan, Garnier & CoBuy -> NeutralN/A
AXAHY
AXA
6/12/2013Reiterated byBryan, Garnier & CoBuy €18.50N/A
AXAHY
AXA
5/24/2013Reiterated byBryan, Garnier & CoBuy €18.50N/A
SAP
SAP
5/8/2013Reiterated byBryan, Garnier & CoBuy €70.00N/A
COD
Compagnie de Saint-Gobain
4/18/2013Reiterated byBryan, Garnier & CoNeutral €32.00N/A
FME
Fresenius Medical Care AG & Co. KGaA
2/15/2013Reiterated byBryan, Garnier & CoBuy €66.37N/A
BEI
Beiersdorf Aktiengesellschaft
1/16/2013Reiterated byBryan, Garnier & CoSell €63.84N/A
IDR
Idaho Strategic Resources
12/11/2012Reiterated byBryan, Garnier & CoSell €8.09N/A
FME
Fresenius Medical Care AG & Co. KGaA
12/6/2012Reiterated byBryan, Garnier & CoBuy €63.17N/A
FME
Fresenius Medical Care AG & Co. KGaA
10/19/2012Reiterated byBryan, Garnier & CoBuy €64.00N/A
SAP
SAP
10/5/2012Reiterated byBryan, Garnier & CoBuy €61.19N/A
BEAM
Beam Therapeutics
9/20/2012Reiterated byBryan, Garnier & CoNeutralN/A
BEAM
Beam Therapeutics
9/12/2012Reiterated byBryan, Garnier & CoNeutralN/A

MarketBeat Community Rating for Bryan, Garnier & Co

Community Ranking:  2.8 out of 5 (
2.8 of 5 stars)
Outperform Votes:  17,755 (Vote Outperform)
Underperform Votes:  14,143 (Vote Underperform)
Total Votes:  31,898
MarketBeat's community ratings are surveys of what our community members think about Bryan, Garnier & Co and other research firms. Vote "Outperform" if you believe Bryan, Garnier & Co's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Bryan, Garnier & Co's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.